Tunicamycin decreases the probability of single-channel openings for N-methyl-D-aspartate and α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors

NeuroReport

Volumn 17, Issue 3, 2006, Pages 313-317

  Maruo, Keishi ^a   Yamamoto, Satoshi ^a   Kanno, Takeshi ^a   Yaguchi, Takahiro ^a   Maruo, Soji ^a   Yashiya, Shinichi ^a   Nishizaki, Tomoyuki ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

amino 3 hydroxy 5 methyl 4 isoxazole propionic acid receptor; N methyl D aspartate receptor; Single channel recording; Tunicamycin

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID RECEPTOR; AMPA RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBTYPE; TUNICAMYCIN; UNCLASSIFIED DRUG;

AGONIST; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; EMBRYO; GLYCOSYLATION; NERVE CELL MEMBRANE; NERVE CELL MEMBRANE CONDUCTANCE; NEUROMODULATION; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROBABILITY; RAT; RECEPTOR BLOCKING; WHOLE CELL;

2-AMINO-5-PHOSPHONOVALERATE; ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG INTERACTIONS; ELECTRIC STIMULATION; EMBRYO; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; HIPPOCAMPUS; ION CHANNEL GATING; KAINIC ACID; MEMBRANE POTENTIALS; N-METHYLASPARTATE; NEURONS; PATCH-CLAMP TECHNIQUES; PROBABILITY; QUINOXALINES; RATS; RATS, WISTAR; REACTION TIME; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE; TUNICAMYCIN;

EID: 33644510157     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnr.0000199458.78670.a0     Document Type: Article

References (10)

1. Sumikawa K, Parker I, Miledi R. Effect of tunicamycin on the expression of functional brain neurotransmitter receptors and voltage-operated channels in Xenopus oocytes. Brain Res 1988; 464:191-199.
2. Sumikawa K, Miledi R. Assembly and N-glycosylation of all ACh receptor subunits are required for their efficient insertion into plasma membranes. Mol Brain Res 1989; 5:183-192.
3. Gehle VM, Sumikawa K. Site-directed mutagenesis of the conserved N-glycosylation site on the nicotinic acetylcholine receptor subunits. Mol Brain Res 1991; 11:17-25.
4. Gehle VM, Walcott EC, Nishizaki T, Sumikawa K. N-glycosylation at the conserved sites ensures the expression of properly folded functional ACh receptors. Mol Brain Res 1997; 45:219-229.
5. Everts I, Villmann C, Hollmann M. N-glycosylation is not a prerequisite for glutamate receptor function but is essential for lectin modulation. Mol Pharmacol 1997; 52:861-873.
6. Nishizaki T, Sumikawa K. Tunicamycin increases desensitization of junctional and extrajunctional acetylcholine receptors expressed in Xenopus oocytes by a mechanism independent of N-glycosylation blocking. Mol Pharmacol 1992; 42:152-156.
7. Nishizaki T, Sumikawa K. Tunicamycin alters channel gating characteristics of junctional and extrajunctional acetylcholine receptors expressed in Xenopus oocytes. Neurosci Lett 1994; 170:273-276.
8. Maruo K, Nagata T, Yamamoto S, Nagai K, Yajima Y, Maruo S, Nishizaki T. Tunicamycin inhibits NMDA and AMPA receptor responses independently of N-glycosylation. Brain Res 2003; 977:294-297.
9. Colquhoun D, Hatton CJ, Hawkes AG. The quality of maximum likelihood estimates of ion channel rate constants. J Physiol 2003; 547:699-728.
10. Hatton CJ, Shelley C, Brydson M, Beeson D, Colquhoun D. Properties of the human muscle nicotinic receptor, and of the slow-channel myasthenic syndrome mutant epsilonL221F, inferred from maximum likelihood fits. J Physiol 2003; 547:729-760.